Immunic | VTL - Current Assets


Immunic reported $188.76M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
BioMarin Pharmaceutical USD 3.97B 633.45M Jun/2026
Cipla INR 241.47B 7.71B Mar/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 137.28M 10.74M Mar/2026
CSL USD 11.85B 1000K Dec/2025
Enanta Pharmaceuticals USD 198.68M 5.65M Dec/2025
Grifols EUR 5.96B 316.31M Dec/2025
Immunic USD 188.76M 165.89M Mar/2026
Insmed USD 1.63B 20.75M Jun/2026
Omeros USD 69.65M 26.53M Jun/2025
OraSure Technologies USD 222.94M 17.84M Jun/2026
Quidel USD 1.38B 400K Jun/2026
Ultragenyx Pharmaceutical USD 606M 51M Jun/2026
United Therapeutics USD 3.48B 611.7M Jun/2026